Literature DB >> 1524702

A case of destructive polyarthropathy in a 17-year-old youth following pefloxacin treatment.

X Chevalier1, E Albengres, M C Voisin, J P Tillement, B Larget-Piet.   

Abstract

Joint and muscle pain have been reported with quinolones; however, arthropathies induced by quinolones do not result in erosive changes in humans, although such changes have occurred in animal studies. We report an unusual case of destructive polyarthropathy in a 17-year-old boy after treatment with pefloxacin 800 mg/day for 3 months. Pefloxacin may have accentuated the cartilage damage in this case, even if an underlying joint disease could not be excluded.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1524702     DOI: 10.2165/00002018-199207040-00007

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  11 in total

1.  [Arthropathy with achilles tendon involvement induced by pefloxacin. Apropos of a case].

Authors:  C Jorgensen; J M Anaya; C Didry; F Canovas; I Serre; P Baldet; P Ribard; M F Kahn; J Sany
Journal:  Rev Rhum Mal Osteoartic       Date:  1991-10

2.  Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations.

Authors:  R Stahlmann; H J Merker; N Hinz; I Chahoud; J Webb; W Heger; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  The diffusion of pefloxacin into bone and the treatment of osteomyelitis.

Authors:  P Dellamonica; E Bernard; H Etesse; R Garraffo
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

Review 4.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

5.  Nalidixic acid arthralgia.

Authors:  R R Bailey; R Natale; A L Linton
Journal:  Can Med Assoc J       Date:  1972-10-07       Impact factor: 8.262

6.  Efficacy and safety of pefloxacin in the treatment of patients with complicated urinary tract infections.

Authors:  J B Boerema; R Pauwels; J Scheepers; W Crombach
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

7.  Ciprofloxacin and tenosynovitis.

Authors:  S R McEwan; P G Davey
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

8.  Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.

Authors:  M Chevais; P Reinert; M C Rondeau; R Tobelem; E Albengres; P Riant; J P Tillement
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1987-06

9.  Morphological investigation of osteochondrosis induced by ofloxacin in rats.

Authors:  M Kato; T Onodera
Journal:  Fundam Appl Toxicol       Date:  1988-07

10.  Avascular necrosis of bone following short-term dexamethasone therapy for brain edema. Case report.

Authors:  A Fast; M Alon; S Weiss; F R Zer-Aviv
Journal:  J Neurosurg       Date:  1984-11       Impact factor: 5.115

View more
  8 in total

Review 1.  Antibiotics and breast-feeding: a critical review of the literature.

Authors:  Allison M Chung; Michael D Reed; Jeffrey L Blumer
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 2.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

3.  A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.

Authors:  G Hayem; C Carbon
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 4.  An update on drug-induced arthritis.

Authors:  Marwan H Adwan
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

Review 5.  Quinolones in children. Are concerns over arthropathy justified?

Authors:  R Stahlmann; C Förster; D Van Sickle
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

Review 6.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

7.  Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy.

Authors:  R Stahlmann; C Förster; M Shakibaei; J Vormann; T Günther; H J Merker
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

8.  Real-world safety evaluation of musculoskeletal adverse events associated with Korean pediatric fluoroquinolone use: a nationwide longitudinal retrospective cohort study.

Authors:  Yoonhye Kim; Minwoo Paik; Chanjoo Khan; Yae-Jean Kim; EunYoung Kim
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.